Hurtubise M R, Bottino J C, Lawson M, McCredie K B
Arch Surg. 1980 Feb;115(2):212-3. doi: 10.1001/archsurg.1980.01380020078018.
Thrombotic occlusion remains a major cause of central venous catheter removal prior to completion of therapy. Injection of a dilute solution of a potent fibrinolytic agent, urokinase or streptokinase, into the occluded Silastic central venous catheter consistently reestablishes its patency. This procedure was performed on 352 occluded silicone elastomer central venous catheters with only one failure and one minor complication. We recommend this technique for restoring patency of occluded silicone elastomer central venous catheters.
血栓形成性闭塞仍然是在治疗完成前拔除中心静脉导管的主要原因。向闭塞的硅橡胶中心静脉导管内注入一种强效纤溶酶(尿激酶或链激酶)的稀释溶液,能够持续恢复其通畅性。该操作应用于352根闭塞的硅橡胶中心静脉导管,仅出现1例失败和1例轻微并发症。我们推荐使用该技术恢复闭塞的硅橡胶中心静脉导管的通畅性。